Preliminary Clinical Study Data Suggests That Celliant Reduces Pain
Main Category: Pain / AnestheticsArticle Date: 21 Feb 2008 - 1:00 PDT
| Patient / Public: | ![]() |
4.25 (8 votes) |
| Health Professional: | ![]() |
5 (3 votes) |
| Article Opinions: | 1 posts |
Already proven to increase oxygen levels in the body, preliminary data from a new clinical study supports claims that Celliant reduces pain.
Celliant is a specially formulated material designed to enhance oxygen levels in the body, aiding in comfort, healing and overall wellness. Early data analysis from a recent clinical study conducted by research scientists affiliated with Long Beach VA Healthcare System and UCI Medical Center suggests that the material also has potent pain relief capabilities. In a double blind study using measurement techniques successfully employed in FDA-supervised clinical trials of pain relief medications, the magnitude of pain relief reported by participants using products enhanced with Celliant was much greater than that reported by participants using placebo products. Hologenix LLC, the company behind Celliant, sponsored the trials.
"We have sponsored a properly designed clinical trial, now complete except for the final statistical analysis. The preliminary data analysis shows a strong trend in favor of Celliant compared to placebo products," explains Dean Jensen, CEO of Hologenix LLC.
These results have obvious implications for the health and medical markets. However, Hologenix believes a broader market for their pain relieving textile exists.
"To date, much of the research conducted on Celliant has been limited to patients with diabetes, or some form of vascular impairment," explains Jensen. "However, many individuals have trouble staying active because of chronic pain-virtually everyone suffers from some sort of ache or pain during their life."
In fact, this most recent study included subjects who suffered from diabetic neuropathic pain as well as a second group of non-diabetic subjects. Both groups experienced significant pain relief. The data showing a greater reduction in pain with Celliant is sufficiently strong that the research team is preparing a manuscript describing the study results for submission to a peer reviewed medical journal, and are not disclosing any further details in order to avoid compromising evaluation of the study by the scientific community.
About Celliant
Celliant is a specially formulated material that is knit, woven or added to fabrics to enhance oxygen levels in the body. Increased oxygen levels have been clinically proven to relieve pain, promote quicker healing, improve sleep quality, heighten athletic performance and improve overall wellness. For more information about products that include Celliant, how Celliant works, or studies that have been conducted on Celliant, please visit http://www.celliant.com.
Products enhanced with Celliant have been clinically proven to relieve pain, increase comfort and aid in healing by increasing oxygen levels and helping to regulate body temperature. Celliant is now available in a variety of products for the sleep, sport, health and life markets.
About Hologenix
Hologenix, LLC, maker of Celliant, is committed to creating, discovering and marketing products that enhance people's lives through pain relief, increased comfort and improved overall well-being. The research that led to the creation of Celliant began in the 1990s when a team of pioneers in the field of alternative medicine visited Asia and observed the use of several natural substances that were thought to have a positive effect on health. After seven years of research and study, the team was able to integrate some of these materials into fabrics that could be made into apparel, bedding and medical products. Hologenix was founded in order to commercialize and bring this material, known as Celliant, to market.
http://www.celliant.com
|
Please rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
| Back to top | Back to front page | List of All Medical Articles |
| Privacy Policy | Terms and Conditions | © 2009 MediLexicon International Ltd |





